02.06.2014
- German drugmaker Boehringer Ingelheim has said it will pay about $650 million to settle US lawsuits that claimed the company's blockbuster blood thinner, Pradaxa (dabigatran)...
29.12.2012
- U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb and Pfizer, for treatment in patients with atrial fibrillation, or irregular...
